67457-991-15 : NDC 2026 Code

67457-991-15 : Trastuzumab ( Ogivri )

Additionally :

You can get information about “67457-991-15” NDC code in 67457-991-15 in HTML format

HTML | 67457-991-15 in TXT (Plain Text) format

TXT | 67457-991-15 in PDF (Portable Document Format)

PDF | 67457-991-15 in XML format

XML formats.

NDC Code : 67457-991-15 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "67457-991-15",
    "PackageDescription": "1 VIAL in 1 CARTON (67457-991-15)  / 15 mL in 1 VIAL",
    "NDC11Code": "67457-0991-15",
    "ProductNDC": "67457-991",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Ogivri",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Trastuzumab",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20191129",
    "EndMarketingDate": "20270228",
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761074",
    "LabelerName": "Mylan Institutional LLC",
    "SubstanceName": "TRASTUZUMAB",
    "StrengthNumber": "150",
    "StrengthUnit": "mg/7.4mL",
    "Pharm_Classes": "HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2023-09-07",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": "20191129",
    "EndMarketingDatePackage": "20270228",
    "SamplePackage": "N"
  }
}